ES2513691T3 - Preparación transdérmica - Google Patents

Preparación transdérmica Download PDF

Info

Publication number
ES2513691T3
ES2513691T3 ES10777667.6T ES10777667T ES2513691T3 ES 2513691 T3 ES2513691 T3 ES 2513691T3 ES 10777667 T ES10777667 T ES 10777667T ES 2513691 T3 ES2513691 T3 ES 2513691T3
Authority
ES
Spain
Prior art keywords
transdermal preparation
support
adhesive layer
indolone
ethylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10777667.6T
Other languages
English (en)
Inventor
Naoyuki Uchida
Yuka Takagi
Yasunori Takada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hisamitsu Pharmaceutical Co Inc
Original Assignee
Hisamitsu Pharmaceutical Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co Inc filed Critical Hisamitsu Pharmaceutical Co Inc
Application granted granted Critical
Publication of ES2513691T3 publication Critical patent/ES2513691T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Preparación transdermica que comprende un soporte y una capa adhesiva laminada sobre el soporte, en la que la capa adhesiva contiene 4-etilen-2(3H)-indolona y un compuesto fisiologicamente activo.

Description

imagen1
imagen2
imagen3
imagen4
imagen5

Claims (1)

  1. imagen1
ES10777667.6T 2009-05-21 2010-05-07 Preparación transdérmica Active ES2513691T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2009123429 2009-05-21
JP2009123429 2009-05-21
PCT/JP2010/057807 WO2010134433A1 (ja) 2009-05-21 2010-05-07 経皮吸収製剤

Publications (1)

Publication Number Publication Date
ES2513691T3 true ES2513691T3 (es) 2014-10-27

Family

ID=43126117

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10777667.6T Active ES2513691T3 (es) 2009-05-21 2010-05-07 Preparación transdérmica

Country Status (7)

Country Link
US (1) US9238025B2 (es)
EP (1) EP2438917B1 (es)
JP (1) JP5514815B2 (es)
KR (1) KR101709361B1 (es)
CN (1) CN102361638B (es)
ES (1) ES2513691T3 (es)
WO (1) WO2010134433A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9918945B2 (en) * 2011-05-31 2018-03-20 Hisamitsu Pharmaceutical Co., Inc. Ropinirole-containing patch and package thereof
US9155710B2 (en) 2011-05-31 2015-10-13 Hisamitsu Pharmaceutical Co., Inc. Ropinirole-containing patch and package thereof
JP6234936B2 (ja) * 2012-11-30 2017-11-22 帝國製薬株式会社 ロピニロール含有貼付剤
CN103494809B (zh) * 2013-09-26 2015-09-09 西安力邦制药有限公司 一种包含罗匹尼罗的组合物的制备方法
WO2016167345A1 (ja) * 2015-04-15 2016-10-20 久光製薬株式会社 ロピニロール含有貼付剤
WO2018155390A1 (ja) 2017-02-24 2018-08-30 久光製薬株式会社 貼付剤及びその包装体
US20220362214A1 (en) 2019-09-18 2022-11-17 Hisamitsu Pharmaceutical Co., Inc. Ropinirole-containing patch and method for improvng skin permeability of ropinirole
JP7202450B2 (ja) 2019-11-26 2023-01-11 久光製薬株式会社 ロピニロール含有貼付剤の粘着剤層保持力向上方法、及びロピニロール含有保持力改善貼付剤
JP7284877B2 (ja) 2020-10-29 2023-05-31 久光製薬株式会社 ロピニロール含有貼付剤及びロピニロールの皮膚透過性向上方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452808A (en) 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
GB8714371D0 (en) 1987-06-19 1987-07-22 Smith Kline French Lab Process
JPH01190658A (ja) 1988-01-26 1989-07-31 Hokuriku Seiyaku Co Ltd フェニルアセトニトリル誘導体
GB9511366D0 (en) * 1995-06-06 1995-08-02 Smithkline Beecham Plc Novel formulations
NZ309980A (en) 1995-06-07 2001-06-29 Noven Pharma Transdermal composition containing a blend of one or more polymers, one or more drugs that has a low molecular weight and is liquid at room temperature
US5807570A (en) 1995-09-29 1998-09-15 Cygnus, Inc. Transdermal administration of ropinirole and analogs thereof
DE19814087A1 (de) * 1998-03-30 1999-10-14 Lohmann Therapie Syst Lts Feuchtigkeitsaktivierbares therapeutisches System
JP2004331500A (ja) 2001-02-16 2004-11-25 Dainippon Pharmaceut Co Ltd 血中濃度制御製剤
WO2005105741A1 (en) 2004-02-11 2005-11-10 Sun Pharmaceutical Industries Limited Substantially pure 4-[2-(di-n-propylamino)ethyl]-2(3h)-indolone hydrochloride
JP5684441B2 (ja) * 2005-12-28 2015-03-11 久光製薬株式会社 インドメタシン含有貼付剤
CA2671636A1 (en) 2006-12-06 2008-06-12 Nipro Patch Co., Ltd. Pharmaceutical composition for external application and adhesive skin patch
JP2008239497A (ja) * 2007-03-23 2008-10-09 Lintec Corp 消炎鎮痛貼付剤
EP2255809B1 (en) 2008-02-27 2017-08-23 Hisamitsu Pharmaceutical Co., Inc. Medicated patch
ES2661767T3 (es) 2008-02-27 2018-04-03 Hisamitsu Pharmaceutical Co., Inc. Parche adhesivo para la piel y producto envasado
KR20120024562A (ko) 2009-04-24 2012-03-14 히사미쓰 세이야꾸 가부시키가이샤 첩부제 수용 포장 백, 및 첩부제의 보존 방법
US9918945B2 (en) * 2011-05-31 2018-03-20 Hisamitsu Pharmaceutical Co., Inc. Ropinirole-containing patch and package thereof

Also Published As

Publication number Publication date
WO2010134433A1 (ja) 2010-11-25
US9238025B2 (en) 2016-01-19
EP2438917B1 (en) 2014-09-03
KR101709361B1 (ko) 2017-02-22
EP2438917A4 (en) 2014-01-22
JP5514815B2 (ja) 2014-06-04
CN102361638A (zh) 2012-02-22
JPWO2010134433A1 (ja) 2012-11-08
EP2438917A1 (en) 2012-04-11
CN102361638B (zh) 2013-07-17
KR20120024582A (ko) 2012-03-14
US20120052113A1 (en) 2012-03-01

Similar Documents

Publication Publication Date Title
ES2513691T3 (es) Preparación transdérmica
ES2502472T3 (es) Composición adhesiva para su uso en un inmunosensor
ES2519166T3 (es) Conjunto de imán
ES2505119T3 (es) Lámina posterior de soporte para módulos fotovoltaicos
ES2523727T3 (es) Procedimiento y dispositivo para producir parche adhesivo
ES2497167T5 (es) Una composición de bebida
ES2605431T3 (es) Mejoras en preimpregnados
ES2629749T3 (es) Inmunidad tumoral
ES2529662T3 (es) Parche adhesivo médico
ES2496791T3 (es) Sistema de capas cerámicas porosas
ES2527242T3 (es) Composiciones que comprenden un germinante y un agente antimicrobiano
ES2602810T3 (es) Composición mejorada
BRPI0909821A2 (pt) polietileno linear de baixa densidade, uso do mesmo, filme coextrudado e laminado contendo um filme.
ES2617360T3 (es) Estructura laminada para la visualización de información
NI201000172A (es) Uso de dronedarona para la preparación de un medicamento para uso en la prevención de la hospitalización cardiovascular o de la mortalidad.
ES2565629T3 (es) Comprimido de adhesión oral bicapa con adhesivo de goma arábiga
CL2007003532A1 (es) Elemento multilaminar que comprende una pelicula de soporte parcialmente transparente de un material laminar estirable en frio, una capa especular semi-transparente, una pelicula parcialmente transparente, y un elemento electroluminiscente; elemento multilaminar 3d; y procedimientos para fabricar los elementos multilaminares
EP2452942A4 (en) SUBSTITUTED BENZOCHALCOGENACEN COMPOUND, THIN LAYER WITH THE CONNECTION AND ORGANIC SEMICONDUCTOR COMPONENT WITH THE THIN LAYER
CL2009000328A1 (es) Forma de dosificacion unitaria que comprende una matriz de pelicula delgada soluble en agua que comprende un copolimero de injerto de polivinilalcohol-polietilenglicol en calidad de polimero de matriz soluble en agua y un estrogeno esteroide como principio activo, en donde la matriz de pelicula tiene un espesor menor a 300 um.
ES2646737T3 (es) Sistema terapéutico transdérmico para clorhidrato de ácido 5-aminolevulínico
ES2586129T3 (es) Bisagra de material compuesto y proceso para su fabricación
EP2711994A3 (en) Light emitting diode
AR058843A1 (es) Panel de barrera
CL2012003031A1 (es) Un metodo para administrar un lugar de investigacion de semillas.
ES2501547T3 (es) Implante médico y prótesis de articulación de rodilla